Learn

Saturday, 21 November

FMGE · blueprint and recall

FMGE Pharmacology

Seen in 19 of the 19 sessions with recall; 11 of the 11 well-covered sessions. Explore the chapters in this subject, then the topics and styles represented in the recall.

Official questions
13
NBEMS subject blueprint
Concept cards
187
unofficial recall collection
Chapters
9
Lumi's outline
Outline topics seen
45
of 49 in the outline

Official allocation and recall share

Official NBEMS shareUnofficial recall share
  • Pharmacology

    Official: 13 questions

    Official share
    4.3%
    Recall share, unofficial
    6.2%

Recall share uses concept appearances across the well-covered sessions. A concept appearing in multiple sessions counts in each of them. It is not an official question distribution. Based on the 11 well-covered sessions. Percentages are shown to one decimal place.

Official source: NBEMS FMGE information bulletin, chapter 12. Chapter and topic groupings are Lumi's outline.

Chapters by recurrence

Ordered by sessions with recall, with well-covered recurrence alongside. Open a chapter for its full topic list.

  1. Pharmacology

    Chemotherapy

    Seen in 17 of the 19 sessions with recall; 11 of the 11 well-covered sessions.

    8 outline topics seen · 37 concepts

  2. Pharmacology

    Cardiovascular & Renal

    Seen in 15 of the 19 sessions with recall; 10 of the 11 well-covered sessions.

    5 outline topics seen · 25 concepts

  3. Pharmacology

    Central Nervous System

    Seen in 14 of the 19 sessions with recall; 9 of the 11 well-covered sessions.

    7 outline topics seen · 21 concepts

  4. Pharmacology

    Autonomic Nervous System

    Seen in 13 of the 19 sessions with recall; 10 of the 11 well-covered sessions.

    5 outline topics seen · 23 concepts

  5. Pharmacology

    Endocrine

    Seen in 13 of the 19 sessions with recall; 9 of the 11 well-covered sessions.

    5 outline topics seen · 20 concepts

  6. Pharmacology

    General Pharmacology

    Seen in 11 of the 19 sessions with recall; 10 of the 11 well-covered sessions.

    5 outline topics seen · 22 concepts

  7. Pharmacology

    Autacoids & Respiratory

    Seen in 11 of the 19 sessions with recall; 10 of the 11 well-covered sessions.

    4 outline topics seen · 18 concepts

  8. Pharmacology

    Blood & GIT

    Seen in 10 of the 19 sessions with recall; 9 of the 11 well-covered sessions.

    5 outline topics seen · 19 concepts

  9. Pharmacology

    Toxicology & Miscellaneous

    Seen in 2 of the 19 sessions with recall; 1 of the 11 well-covered sessions.

    1 outline topics seen · 2 concepts

Topics seen in the most sessions

The outline topics with the widest recurrence in this subject's unofficial recall.

  • Chemotherapy

    Anticancer drugs

    Seen in 14 of the 19 sessions with recall; 10 of the 11 well-covered sessions.

    First seen: FMGE Jun 2009. Last seen: FMGE Jan 2026.

    Styles: one-liner (10) · vignette (3).

  • Endocrine

    Insulin and oral antidiabetics

    Seen in 10 of the 19 sessions with recall; 8 of the 11 well-covered sessions.

    First seen: FMGE Jun 2009. Last seen: FMGE Jul 2025.

    Styles: one-liner (8) · vignette (2).

  • Central Nervous System

    Antiepileptics

    Seen in 10 of the 19 sessions with recall; 7 of the 11 well-covered sessions.

    First seen: FMGE Jun 2009. Last seen: FMGE Jan 2025.

    Styles: one-liner (6) · vignette (2) · image + vignette (1).

  • Cardiovascular & Renal

    Antihypertensives

    Seen in 9 of the 19 sessions with recall; 7 of the 11 well-covered sessions.

    First seen: FMGE Jun 2009. Last seen: FMGE Jul 2025.

    Styles: one-liner (5) · vignette (4) · image-ID (1).

  • Cardiovascular & Renal

    Diuretics

    Seen in 9 of the 19 sessions with recall; 6 of the 11 well-covered sessions.

    First seen: FMGE Dec 2010. Last seen: FMGE Jan 2025.

    Styles: one-liner (4) · vignette (3) · image + vignette (1) · image-ID (1).

  • Blood & GIT

    Anticoagulants and antiplatelets

    Seen in 8 of the 19 sessions with recall; 7 of the 11 well-covered sessions.

    First seen: FMGE Jun 2009. Last seen: FMGE Jul 2025.

    Styles: one-liner (8) · vignette (2).

  • Autonomic Nervous System

    Adrenergic blockers

    Seen in 8 of the 19 sessions with recall; 6 of the 11 well-covered sessions.

    First seen: FMGE Jun 2009. Last seen: FMGE Jan 2023.

    Styles: one-liner (7) · vignette (2).

  • Autonomic Nervous System

    Cholinergic drugs

    Seen in 8 of the 19 sessions with recall; 6 of the 11 well-covered sessions.

    First seen: FMGE Dec 2009. Last seen: FMGE Jan 2025.

    Styles: one-liner (3) · vignette (2).

  • Autacoids & Respiratory

    Drugs for asthma and cough

    Seen in 6 of the 19 sessions with recall; 6 of the 11 well-covered sessions.

    First seen: FMGE Jun 2009. Last seen: FMGE Jul 2025.

    Styles: one-liner (6) · vignette (2).

  • General Pharmacology

    Pharmacodynamics

    Seen in 6 of the 19 sessions with recall; 6 of the 11 well-covered sessions.

    First seen: FMGE Dec 2018. Last seen: FMGE Jan 2023.

    Styles: one-liner (5) · image-ID (2).

  • Chemotherapy

    Antimalarials and anthelmintics

    Seen in 6 of the 19 sessions with recall; 5 of the 11 well-covered sessions.

    First seen: FMGE Jun 2009. Last seen: FMGE Jul 2025.

    Styles: one-liner (4) · vignette (1).

  • Autacoids & Respiratory

    Drugs for gout and rheumatoid arthritis

    Seen in 6 of the 19 sessions with recall; 5 of the 11 well-covered sessions.

    First seen: FMGE Jun 2011. Last seen: FMGE Jan 2023.

    Styles: one-liner (3) · vignette (2).

Question styles and image links

Question styles in the recall

one-liner
132 concepts · 70.6%
vignette
48 concepts · 25.7%
image-ID
4 concepts · 2.1%
image + vignette
3 concepts · 1.6%